000			01911 a2200493 4500
005			20250513074815.0
264		0	_c19930629
008			199306s 0 0 eng d
022			_a0732-183X
024	7		_a10.1200/JCO.1993.11.6.1039 _2doi
040			_aNLM _beng _cNLM
100	1		_aSandoval, C
245	0	0	_aSecondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cJun 1993
300			_a1039-45 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAcute Disease
650	0	4	_aAdolescent
650	0	4	_aAlkylating Agents _xadverse effects
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aChild
650	0	4	_aCombined Modality Therapy
650	0	4	_aDactinomycin _xadverse effects
650	0	4	_aDoxorubicin _xadverse effects
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIntercalating Agents _xadverse effects
650	0	4	_aLeukemia, Myeloid _xetiology
650	0	4	_aMale
650	0	4	_aNeoplasms, Second Primary _xetiology
650	0	4	_aPodophyllotoxin _xadverse effects
650	0	4	_aRadiotherapy _xadverse effects
650	0	4	_aTopoisomerase II Inhibitors
650	0	4	_aTranslocation, Genetic
700	1		_aPui, C H
700	1		_aBowman, L C
700	1		_aHeaton, D
700	1		_aHurwitz, C A
700	1		_aRaimondi, S C
700	1		_aBehm, F G
700	1		_aHead, D R
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 11 _gno. 6 _gp. 1039-45
856	4	0	_uhttps://doi.org/10.1200/JCO.1993.11.6.1039 _zAvailable from publisher's website
999			_c8388191 _d8388191